<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05022888</url>
  </required_header>
  <id_info>
    <org_study_id>BYIERH3</org_study_id>
    <nct_id>NCT05022888</nct_id>
  </id_info>
  <brief_title>Near-Infrared Spectroscopy in Myofascial Pain Syndrome</brief_title>
  <official_title>Investigation of the Diagnostic Effect of Muscle Tissue Oxygenation Values in Patients With Myofascial Pain Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bursa Yüksek İhtisas Education and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bursa Yüksek İhtisas Education and Research Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Myofascial pain syndrome is a regional pain syndrome accompanied by sensorial, motor and&#xD;
      autonomic symptoms . myofascial trigger points are most frequently detected in the upper&#xD;
      trapezius, levator scapula, and axial postural muscles such as rhomboid major. Myofascial&#xD;
      pain syndrome is characterized by active myofascial trigger points in the form of focal&#xD;
      hyperirritable nodules palpated in the tight band of the muscle .&#xD;
&#xD;
      Alteration of tissue vascularization could limit or prevent th may cause adhesions,&#xD;
      contractures and pain. As a result of decreased blood flow, tissue oxygenation may decrease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, it will be tried to determine the role of muscle tissue oxygenation in the&#xD;
      activity and diagnosis of the disease in myofascial pain syndrome.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 23, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 23, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>prospective</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>regional tissue saturation</measure>
    <time_frame>15 minute</time_frame>
    <description>tissue oxygen saturation measured from 4 different regions defined on the trapezius muscle. The NIRS probe will be used in these areas.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>peripheral oxygen saturation</measure>
    <time_frame>15 minute</time_frame>
    <description>A pulse oximeter will be used to measure peripheral oxygen saturation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale (VAS)</measure>
    <time_frame>6 month</time_frame>
    <description>for pain. 0: no pain at all, 10: worst pain imaginable</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Myofascial Pain Syndrome</condition>
  <condition>Regional Tissue Oxygen Saturation</condition>
  <arm_group>
    <arm_group_label>myofascial pain syndrome</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients diagnosed with myofascial pain syndrome Tissue oxygen saturation measured from 4 different regions defined on the trapezius muscle</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Healthy volunteers Tissue oxygen saturation measured from 4 different regions defined on the trapezius muscle</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>regional tissue saturation</intervention_name>
    <description>tissue oxygen saturation measured from 4 different regions defined on the trapezius muscle. The NIRS probe will be used in these areas.</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>myofascial pain syndrome</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18-65 years old&#xD;
&#xD;
          -  myofascial pain syndrome&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cervical radiculopathy&#xD;
&#xD;
          -  Fibromyalgia&#xD;
&#xD;
          -  Shoulder joint disease,&#xD;
&#xD;
          -  Peripheral and central nervous system disease&#xD;
&#xD;
          -  Polyneuropathy,&#xD;
&#xD;
          -  Inflammatory rheumatic disease,&#xD;
&#xD;
          -  Malignancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Burcu M.D Metin ÖKMEN, Assoc. PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Korgün MD Ökmen, Assoc. PhD.</last_name>
    <role>Study Chair</role>
    <affiliation>University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Burcu M.D Metin ÖKMEN, Assoc. PhD.</last_name>
    <phone>+902242955000</phone>
    <email>burcumetinokmen@gmail.com</email>
  </overall_contact>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 21, 2021</study_first_submitted>
  <study_first_submitted_qc>August 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 26, 2021</study_first_posted>
  <last_update_submitted>August 25, 2021</last_update_submitted>
  <last_update_submitted_qc>August 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bursa Yüksek İhtisas Education and Research Hospital</investigator_affiliation>
    <investigator_full_name>Dr. Burcu Metin Ökmen</investigator_full_name>
    <investigator_title>Principal Investigator ,Assoc. PhD. M.D.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Somatoform Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

